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Abstract 
Na ÷ transport in renal epithelia is regulated by a wide variety of endogenous and exogenous cellular factors. Although most 
natriferic agents have an action on the amiloride-sensitive Na ÷ channel, the biochemical pathways which precede activation of 
the channel remain incompletely defined. One approach to dissecting such intricate pathways is to perturb a specific cellular 
process and determine its importance in the postulated mechanism. The current studies examine the effect of brefeldin A (BFA), 
an inhibitor of the central vacuolar system, on basal as well as aldosterone-, insulin-, a d forskolin-stimulated Na ÷ transport. In 
the A6 cell line, BFA had a time-dependent effect on basal transport. Aldosterone-induced Na ÷ transport was sensitive toBFA 
while insulin's action was only partially blocked and forskolin-stimulated Na + transport was relatively resistant to the action of 
the inhibitor. These studies highlight differences as well as points of convergence in the natriferic pathways. 
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I. Introduction 
In Na + absorbing epithelia, transcellular Na + trans- 
port is a multistep process. Under normal conditions, 
Na + enters the cells passively through amiloride-sensi- 
tive Na ÷ channels in the apical membrane, transverses 
the cell, and is actively extruded across the basolateral 
plasma membrane by Na+/K+-ATPase [1,2]. While the 
structure, function and regulation of Na+/K+-ATPase 
have been well characterized [3-5], comparatively little 
is known about the apical Na ÷ channel. Benos et al. 
have identified this transporter in bovine kidney and 
the A6 cell line as a heteroligomeric protein of approx- 
imately 730 kDa which can be reduced to 5 or 6 
non-identical subunits having molecular weights rang- 
ing from 40 to 300 kDa [6]. The diuretic amiloride 
inhibits transport hrough the holochannel by binding 
to one of these, a 150-kDa subunit [6]. 
The apical membrane Na ÷ channel appears to be 
the primary site of action of natriferic hormones uch 
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as aldosterone, insulin and vasopressin. Aldosterone's 
action is dependent on new protein synthesis. While 
several potential mediators have been postulated 
[2,5,7-12], the exact nature of the aldosterone-induced 
proteins remains speculative. Consistent with the re- 
quirement for new protein synthesis, aldosterone's 
stimulation of Na + transport is manifested over a 
period of hours. The peptide hormones, insulin and 
vasopressin both stimulate Na + transport in a more 
acute manner that is independent of new protein syn- 
thesis [13-20]. The action of vasopressin is immediate 
and is mediated by changes in intracellular cAMP. 
Insulin's stimulation of Na + transport can be detected 
several minutes after hormone addition and is not 
associated with changes in intracellular cAMP [16]. 
Whether the actions of the peptide hormones require 
membrane protein recycling pathways is an unresolved 
issue. Therefore, it is known that each of these effec- 
tors modulates Na + transport in a distinct manner; 
however, the precise mechanisms remain undefined. 
One approach to dissecting pathways involved in the 
regulation of Na + transport is to perturb one or more 
steps in the chain of events leading to stimulation of 
the amiloride-sensitive Na + channel. One agent that 
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has been particularly useful in studies examining intra- 
cellular trafficking is brefeldin A (BFA). Physio- 
logically, BFA is known to inhibit secretory pathways; 
morphologically, this is accompanied by a disintegra- 
tion of the Golgi apparatus and a redistribution of 
some Golgi proteins into the ER [21-26]. More recent 
studies have indicated that, in some cells, BFA also 
affects the endosomal system and the trans-Golgi net- 
work [21,27-30]. We have examined the effects of two 
concentrations of BFA on basal as well as aldosterone- 
insulin- and forskolin-stimulated Na + transport in a 
model of the mammalian distal nephron, the A6 cell 
line. 
2. Materials and methods 
Materials. Brefeldin A (BFA) was obtained from 
Epicentre Technologies (Madison, WI). Aldosterone, 
forskolin and amiloride were purchased from Sigma 
(St. Louis, MO). Insulin was provided by Eli Lilly 
(Indianapolis, IN). Culture medium was produced by 
Gibco (Grand Island, NY) and fetal bovine serum was 
obtained from ICN/Flow (Costa Mesa, CA). Modified 
Ussing chambers and automated current-voltage clamps 
were obtained from World Precision Instruments (New 
Haven, CT). 
Stock solutions of BFA (in ethanol), aldosterone 
(10 .3 M in methanol) and forskolin (10 -2 M in ethanol) 
were kept at -20°C. Insulin stock solutions (100 ~M 
in 5 mM HCI) were maintained at 4°C. 
Cell culture. A6 cells derived from the kidney of 
Xenopus laet,is were obtained from the American Type 
Culture Collection and cultured in an amphibian Dul- 
becco's modified Eagle's medium as previously de- 
scribed [11]. After amplification in plastic flasks, con- 
fluent monolayers were subcultured by mild trypsiniza- 
tion and the cells seeded (10 6 cells/cm 2) on Nucleo- 
pore polycarbonate membranes forming the bottom of 
Transwell chambers (Costar, Cambridge, MA). The 
Transwells were placed in tissue culture cluster plates 
forming a two-compartment system and allowing media 
access to both apical and basolateral faces of the 
adhered cells. All studies were performed using cells 
grown on Transwells. 
Electrophysiological measurements. For electrophysi- 
ological studies, cells which had been maintained in 
filter culture for 12-20 days were placed in modified 
Ussing chambers and measurements of potential dif- 
ference and short circuit current (SCC) were per- 
formed as previously described [11]. SCC has been 
shown to equal net Na + flux for basal, aldosterone-and 
insulin-stimulated tissues [11,14,16,31]. Amiloride-sen- 
sitive SCC was used as a measure of the Na + flux in 
forskolin-treated cells. 
Electron microscopy studies. Prior to fixation, A6 
cells were preincubated with 0.1 or 2.8/zg/ml BFA for 
30 rain followed by a 30 min incubation in the presence 
or absence of 10 5 M forskolin. Immediately after 
incubation, the cells were rinsed with PBS and fixed 
for 1 h in 2% glutaraldehyde, 6 mM eserine in PBS at 
4°C. The Transwells were transferred to fresh PBS, 
washed briefly and postfixed for 1 h at 4°C with 2% 
OsO4 in 0.1 M sodium cacodylate buffer (pH 7.4). The 
cells were washed with deionized water, stained en 
bloc with 2% aqueous uranyl acetate and dehydrated 
with a graded ethanol series and propylene oxide. The 
membrane filters were separated from the plastic in- 
serts and rolled up. The cells were infiltrated with 
Spurr resin (Electron Microscopy Sciences, Fort Wash- 
ington, PA). The rolled membranes were cut into sev- 
eral pieces and placed in flat embedding molds. Fresh 
resin was added and cured at 70°C for 48 h. Thin 
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Fig. 1. Effect of brefeldin A on aldosterone-stimulated Na + transport. Brefeldin and aldosterone were added to parallel cultures of A6 cells at 
time 0. The control received diluent only. Bars denote S.E. at each time point. * Denotes values higher (aldosterone-treated) or lower 
(BFA-treated) than control levels; P < 0.05. + Denotes values higher than BFA-treated; P < 0.05. 
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Fig. 2. Effect of brefeldin A on insulin-stimulated Na + transport. Brefeldin was added to A6 cell cultures at time -30  min. Insulin was added to 
the cultures at time 0. The control received diluent only. Bars denote S.E. at each time point. Where no bars are shown, the S.E. is smaller than 
the symbol used to denote the mean. * Denotes values higher (insulin-treated) or lower (BFA-treated) than control levels; P < 0.02 and P < 0.05, 
respectively. ÷ denotes values higher than BFA-treated; P < 0.02. 
mounted on copper grids and stained with uranyl ac- 
etate and bismuth subnitrate. Ceils were observed and 
photographed in a JEOL 100CX electron microscope. 
Statistics. The data are presented as means + S,E. 
with n indicating the number of different experiments. 
Comparisons were performed using Student's t-test for 
unpaired samples; values of P < 0.05 were considered 
significant. 
3. Results 
These studies examined the ffects of BFA on base- 
line and hormone-stimulated Na + transport in a model 
of the distal nephron. Aldosterone is a steroid hor- 
mone which stimulates Na ÷ transport in a protein 
synthesis dependent manner; insulin is a peptide hor- 
mone which stimulates Na + transport in a protein 
synthesis independent manner; forskolin increases the 
intracellular concentration of cAMP thereby mimicking 
the effect of vasopressin, another natriferic peptide 
hormone whose action is independent of new protein 
synthesis. 
Fig. 1 illustrates the effects of two concentrations of 
BFA on basal and aldosterone-stimulated Na ÷ trans- 
port. Both concentrations of the inhibitor suppress 
baseline Na ÷ transport after 150 min of incubation. 
Compared to control (non-treated) cells, both 0.1 
and 2.8 /xg/ml BFA completely inhibit aldosterone- 
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Fig. 3. Effect of brefeldin A on forskolin-stimulated Na ÷ transport. Brefeldin was added to A6 cell cultures at time -30  rain. Insulin was added 
to the cells at time 0. The control received diluent only. Bars denote S.E. at each time point. Where no bars are shown the S.E. is smaller than 
the symbol used to denote the mean. * Denotes values significantly higher than control; P < 0.05. + Denotes values significantly higher than 
BFA-treated; P < 0.05. 
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BFA-inhibited baseline conditions, aldosterone is able 
to counteract a portion of the Na + transport inhibited 
by 0.1 /zg/ml BFA. 
Transepithelial resistances were continuously moni- 
tored during the course of these experiments. BFA had 
no effect on resistances of either basal or hormone- 
treated monolayers. 
Fig. 2 illustrates the effect of BFA on insulin-stimu- 
lated Na + transport. Since the natriferic action of 
insulin is acute, inhibitor-treated cells were pre-equi- 
librated with BFA for 30 rain before hormone addition. 
In matched cell cultures, BFA also inhibits basal Na + 
transport; at 0.1 /zg/ml BFA this effect is not statisti- 
cally significant while at 2.8 /zg/ml, the basal inhibi- 
tion is evident after 1.5 h of BFA treatment. 
The addition of insulin to A6 cells stimulates a rapid 
increase in Na + transport which reaches a maximum at 
approximately 1 h. Thereafter, the level of Na + trans- 
port reaches a plateau and after another hour begins to 
decline. 0.1 #g/ml  BFA has no effect on the initial 
insulin-stimulated increase in Na + transport. At longer 
incubation times, the low BFA concentration begins to 
manifest an inhibitory effect while 2.8 /zg/ml BFA 
partially inhibits insulin's natriferic action at early time 
points and shows a more substantial inhibition at later 
time points. 
Forskolin activates adenylate cyclase and mimics the 
action of vasopressin in renal epithelia. While vaso- 
pressin's action is usually transient [2,14,19], the action 
of forskolin in these studies resulted in a prolonged 
activation of Na + transport (Fig. 3). We examined the 
action of forskolin only over the relatively short time- 
course congruent with the action of vasopressin. Within 
this short time-frame, BFA has no discernable ffect 
on baseline Na + transport. Analogous to the insulin 
study, the A6 cultures were pretreated with BFA for 30 
rain. Neither concentration of BFA inhibited the initial 
natriferic response to the increased intracellular cAMP 
and only a very modest inhibition was evident 1 h after 
the addition of forskolin to BFA-pretreated cells. 
Other investigators have reported that in A6 cells 
the increased SCC, which is stimulated in response to 
cAMP, has an amiloride-insensitive component [20]. 
Our results substantiate the previous findings (Table 
1). Interestingly, it is the amiloride-sensitive portion of 
the SCC that is sensitive to the high dose of BFA. 
Although BFA may modulate several intracellular 
trafficking patterns, the best described action of the 
inhibitor is a reversible effect on the structure of the 
Golgi and a consequent blocking of protein movement 
through this pathway. It has been reported that in 
other renal epithelia [25] this inhibition can be re- 
versed by forskolin. 
Fig. 4 shows electron micrographs of six A6 cultures 
which were grown in tandem on nucleopore filters and 
incubated under various experimental conditions. In 
Table 1 
Effect of amiloride (10 5 M) on forskolin-stimulated Na+ transport 
SCC SCC after ASCC 
amiloride 
Forskolin (n = 4) 6.41 + 1.36 2.54 ± 0.54 3.86_+ 0.84 
Forskolin +0. l  #g/ml  BFA 4.59±0.45 2.25 ±0.37 2.36±0.28 
Forskolin (n -  3) 7.70+0.15 2.49±0.26 5.21 _+0.29 
Forskol in+2.8/~g/ml  BFA 5.76±0.50 3.06+0.72 2.70+(I.35 
Short-circuit current (SCC) in /xA/cm 2 was measured 60 rain after 
the addition of forskolin. Amiloride was added immediately and the 
SCC after amiloride was determined 10 rain later. 
each panel a portion of the nucleus is shown on the 
right-hand side for orientation. Normal Golgi are found 
in the control ceils (Fig. 4 A). No Golgi were identified 
in cells which had been treated with 0.1 or 2 .8 /zg/ml  
BFA for 30 or 60 rain (Figs. 4 B-D).  In contrast to 
studies in normal rat kidney (NRK) cells [25], the 
addition of forskolin was unable to reverse the BFA-in- 
duced disruption of the Golgi (Figs. 4 E and F). 
4. Discussion 
One of the first functional consequences attributed 
to BFA was an inhibition of protein secretion [24]. 
Morphologically, this action is associated with a disap- 
pearance of the characteristic structures of the Golgi 
apparatus and retrieval of Golgi proteins into the en- 
doplasmic reticulum [32,33]; biochemically, this ap- 
pears to be due to an inhibition of the guanine-nucleo- 
tide associated binding of a regulatory coat protein of 
the Golgi [21,23,34,35]. 
Recently, it has been demonstrated that BFA may 
have other actions in the central vacuolar system 
[23,27-29]. In some renal epithelial cells, concentra- 
tions of BFA that did not disrupt Golgi structures 
inhibited targeting of apical (but not basolateral) pro- 
teins to the cell surface [28] and also blocked transcyto- 
sis of proteins from the basolateral to apical plasma 
membrane [27]. 
BFA has been widely used to study protein traffick- 
ing [21-23] and is a valuable tool that can be used to 
dissect the complex pathways involved in hormonally 
regulated ion transport. We have used two concentra- 
tions of BFA to examine hormonally regulated Na + 
transport in A6 cells. 
In MDCK cells, 10 /zM BFA selectively inhibits 
transcytosis of proteins from the basolateral to apical 
plasma membrane with no effect on the Golgi appara- 
tus [27]. In contrast o those findings, we were unable 
to observe intact Golgi after incubation in the presence 
of either 2 .8/zg/ml  (10/zM) or 0.1 /~g/ml BFA (Figs. 
4 B-D).  In this regard, the sensitivity of the A6 cell 
line is more analogous to normal rat kidney cells [25], 
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Fig. 4. Effect of brefeldin A on Golgi apparatus in A6 cells. A6 cells were prepared for electron microscopy after incubation u der the following 
conditions: (A) Control, cells were incubated in media for 1 h; (B) low dose brefeldin, cells were incubated with 0.1 /xg/ml brefeldin A for 60 
min; (C) high dose brefeldin, cells were incubated with 2.8 p~g/ml brefeldin A for 30 min; (D) high dose brefeldin, cells were incubated with 2.8 
p,g/ml brefeldin A for 60 rain; (E) low dose brefeldin + forskolin, cells were incubated with 0.1 txg/ml brefeldin A for 60 rain, 10/~M forskolin 
was added to the media for the final 30 min of this incubation; (F) high dose brefeldin + forskolin, cells were incubated with 2.8 ~g/ml  brefeldin 
A for 60 min, 10 /zM forskolin was added to the media for the final 30 min of this incubation, g = Golgi apparatus; arrows indicate junctional 
complexes. Magnification: 20000 x ; scale bar = 1 p.m. 
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hepatocytes [32], and mouse pituitary cells [33] than to 
the MDCK cell line. Therefore, it is likely that any 
process requiring protein trafficking through the Golgi 
will be blocked at the concentration used in these 
studies. 
Perhaps the most intriguing and unexpected finding 
from these studies was the effect of BFA on basal Na ÷ 
transport. Although the magnitude of the effect was 
directly proportional to the initial transport rate (mea- 
sured as SCC), BFA clearly inhibited basal Na ÷ trans- 
port within 2-3 h of inhibitor addition (Figs. 1 and 2). 
Our results are in agreement with a preliminary report 
from Johnson and Grillo [36] and suggest hat some 
component of the basal Na + transport machinery is 
undergoing active synthesis and/or  recycling in a man- 
ner that is BFA-sensitive. Whether the effect is mani- 
fested on the holochannel, a subunit of the channel or
another component of the transport pathway is un- 
known. However, it is interesting that this dynamic flux 
in the transport pathway exhibits a relatively short 
time-course. 
The precise mechanisms by which natriferic hor- 
mones modulate the activity of the amiloride-sensitive 
Na + channel remain undefined. It is, therefore, diffi- 
cult to assess the correct formulation of data presenta- 
tion. Empirically, we have noted that aldosterone and 
vasopressin stimulate a geometric increase in Na + 
transport while insulin-stimulated transport is best ex- 
pressed as an arithmetic increase (Blazer-Yost, B. and 
Cox, M., unpublished observations). Therefore, we have 
chosen to present he transport data in an unmodified 
form (Figs. 1-3). 
Numerous studies have shown that stimulation of 
transcellular Na + transport by aldosterone requires 
new protein synthesis [2,5,7-9,11,12]. However, the x- 
act nature of the newly synthesized proteins is unclear. 
Immunolocalization and biochemical labelling studies 
have suggested that aldosterone does not induce the 
holochannel form of the Na + transporter [10,37,38]. 
However, a 2D-PAGE comparison of complexes from 
control and aldosterone-treated toad urinary bladder 
and A6 cells has demonstrated that a single heteroge- 
neous subunit (M r ~ 65-70 kDa) is induced by aldos- 
terone [10-12]. This appears to be the only channel 
subunit which is actively synthesized in response to 
aldosterone [10]. As expected from the protein-synthe- 
sis dependent nature of the aldosterone response, the 
action of this steroid hormone is sensitive to both 
concentrations of BFA. 
In contrast o aldosterone, the stimulatory effect of 
insulin on Na + transport is independent of new pro- 
tein synthesis. Insulin's action is initiated by peptide 
binding to a basolateral receptor and within minutes 
culminates in a stimulation of amiloride-sensitive Na + 
transport [13,14,16,39]. Although the intracellular path- 
ways linking receptor binding to channel activation are 
unknown, the level of cAMP does not change in re- 
sponse to insulin [16]. Recently, Marunaka et al. have 
used patch clamp techniques in A6 cells to demon- 
strate that insulin increases the open probability of the 
amiloride-sensitive Na÷ channel with no effect on sin- 
gle channel conductance [39]. This study has elegantly 
validated earlier, less direct, investigations suggesting 
that the insulin-stimulated natriferic pathway has a 
primary effect on the amiloride-sensitive Na ÷ channel 
[40,41]. 
0.1/xg/ml BFA has no effect on the initial increase 
in insulin-stimulated Na ÷ transport (Fig. 2 A). At the 
low inhibitor concentration, the moderate inhibition of 
insulin-stimulated Na ÷ transport at later time points 
(t > 30 min) parallels a BFA-induced decrease in basal 
transport and the degree of hormone stimulation does 
not appear to be affected by the inhibitor. In contrast, 
2.8/xg/ml BFA partially inhibits insulin's action in A6 
cells and the magnitude of the inhibition appears to be 
greater than the suppression f basal transport. 
Arginine vasopressin also acutely stimulates tran- 
scellular Na ÷ transport in a protein synthesis inde- 
pendent manner. Like insulin, vasopressin binds to a 
basolateral receptor; however, in contrast to insulin, 
receptor binding stimulates adenylate cyclase resulting 
in an increase in cAMP and a stimulation of protein 
kinase A. The action of vasopressin is associated with a 
protein kinase A-dependent phosphorylation of the 
300-kDa subunit of the Na ÷ channel [42]. 
To determine the physical mechanism by which va- 
sopressin stimulates the Na ÷ channel, Garty and Edel- 
man [43] studied Na ÷ channel functional expression 
under conditions of limited proteolysis. In the toad 
urinary bladder, incubation of the mucosal surface with 
trypsin irreversibly inhibits 50% of basal Na ÷ trans- 
port. In contrast, trypsin incubation did not inhibit a 
subsequent response to vasopressin suggesting that one 
of the actions of this peptide hormone is to facilitate 
the insertion of functional Na ÷ channels from a 
trypsin-insensitive pool. 
More recently, labeling studies in the A6 cell line 
have indicated that vasopressin did not induce the 
apical insertion of new Na ÷ channels. In addition, 
protein kinase A phosphorylation of the 300-kDa sub- 
unit of the channel was accompanied by an increase in 
the open probability of reconstituted channels. The 
authors interpret these results to indicate that vaso- 
pressin activates channels already present in the apical 
membrane [42]. 
The A6 cell line is moderately sensitive to arginine 
vasopressin while the analogous amphibian peptide 
hormone, arginine vasotocin, exhibits a greater potency 
[18]. However, the natriferic action of both peptides is 
accompanied by an increase in intracellular cAMP. 
The diterpene, forskolin, stimulates the catalytic sub- 
unit of adenylate cyclase [44] and induces a higher level 
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of intracellular cAMP than arginine vasopressin [45] 
and a more stable transport response in the A6 cell 
line [20]. In the current studies, forskolin was used to 
mimic the action of vasopressin. 
In the normal rat kidney cell line (NRK), forskolin 
reverses the morphological effect of BFA by a cAMP- 
independent mechanism [25]. In our studies, the con- 
centration of forskolin (10 ~M) necessary to stimulate 
cAMP and, consequently, Na ÷ transport, was unable 
to reverse the morphological effect of BFA (Figs. 4 
E-F).  This may represent a difference between the two 
cell lines or a concentration-dependent phenomena. 
Concentrations greater than 50 tzM were necessary to 
reverse BFA effects in NRK ceils [25]. We have as- 
sumed, therefore, that the major action of forskolin in 
the natriferic pathway is a cAMP-mediated stimulation 
of ion transport. 
In amphibian model systems, basal as well as aldos- 
terone and insulin-stimulated Na + transport is com- 
pletely amiloride-sensitive [14,31]. However, as noted 
by previous investigators [20,45], the forskolin-stimu- 
lated increase in transcellular transport was not com- 
pletely blocked by amiloride (Table 1). The amiloride- 
insensitive component of this response has been shown 
by others to be due to an increase in transcellular C1- 
flux [20]. 
Over the time course where vasopressin would be 
expected to manifest its actions, the forskolin-induced 
increase in transport is not significantly affected by 
BFA (Fig. 3). After 1 h, 2 .8/zg/ml  of the inhibitor can 
suppress a minor portion of the forskolin-stimulated 
transport and the inhibited transport appears to be 
amiloride-sensitive Na ÷ flux (Table 1). In view of the 
time-course of action of this peptide hormone, inhibi- 
tion after 30 min is unlikely to be physiologically rele- 
vant. If the major mechanism for forskolin action is the 
insertion of new channels from a trypsin-insensitive 
pool (presumably an intracellular pool) then this shut- 
tling/insertion is not sensitive to BFA. 
These studies have provided additional insight into 
the complex question of h w the biochemical pathways 
involved in transcellular Na + transport are regulated. 
The inhibitory effect of BFA on normal, basal Na ÷ 
transport suggests a dynamic process occurring in the 
absence of hormonal stimulation. This normal synthe- 
sis and/or  cycling of components of the Na ÷ transport 
machinery should be considered as a factor when de- 
signing controlled studies of the mechanisms of hor- 
mone-stimulated transport phenomena. 
The differential effects of BFA on basal and hor- 
monal-regulated Na ÷ transport may represent diverse 
sensitivity of signal transduction pathways, diverse ac- 
tions on the amiloride-sensitive Na ÷ channel and/or  
the presence of multiple forms of the channel which 
are regulated independently. Future studies examining 
the effect of BFA on known steps in the Na + transport 
pathway or biochemical modification of the Na ÷ chan- 
nel will provide answers to some of the issues raised by 
these studies. 
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